|
RFC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75615078035207E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.10436137801662E-12 |
| Normal-vs-Stage2 |
2.22319999998444E-06 |
| Normal-vs-Stage3 |
8.39819991327317E-10 |
| Normal-vs-Stage4 |
2.55459986497897E-10 |
| Stage1-vs-Stage2 |
6.914400E-01 |
| Stage1-vs-Stage3 |
6.670400E-01 |
| Stage1-vs-Stage4 |
2.065200E-01 |
| Stage2-vs-Stage3 |
5.322800E-01 |
| Stage2-vs-Stage4 |
1.809370E-01 |
| Stage3-vs-Stage4 |
3.664000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.92619311798626E-14 |
| Normal-vs-AfricanAmerican |
6.123000E-03 |
| Normal-vs-Asian |
7.47149999646979E-08 |
| Caucasian-vs-AfricanAmerican |
5.299900E-02 |
| Caucasian-vs-Asian |
7.767200E-01 |
| AfricanAmerican-vs-Asian |
1.233560E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.88813458996174E-13 |
| Normal-vs-Female |
8.94184726263347E-12 |
| Male-vs-Female |
9.692300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.24470467055949E-11 |
| Normal-vs-Age(41-60Yrs) |
5.50880452365732E-11 |
| Normal-vs-Age(61-80Yrs) |
4.83589945865504E-10 |
| Normal-vs-Age(81-100Yrs) |
4.055900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.914000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.754200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.168200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.415600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.498000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.037400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.431560E-01 |
| Classical-VS-Follicular |
4.364200E-01 |
| Classical-VS-Other |
2.549000E-01 |
| Classical-VS-Normal |
9.22928400370893E-12 |
| Tall-VS-Follicular |
4.208000E-01 |
| Tall-VS-Other |
7.024800E-01 |
| Tall-VS-Normal |
8.57059999637144E-08 |
| Follicular-VS-Other |
5.014200E-01 |
| Follicular-VS-Normal |
3.59870000465889E-08 |
| Other-VS-Normal |
1.295560E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.47819978479902E-10 |
| Normal-vs-N1 |
2.32780461573157E-11 |
| N0-vs-N1 |
1.833600E-02 |
|
|
